Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

7.0K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
7.0K
The Thyroid Gland01:23

The Thyroid Gland

6.5K
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
6.5K
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

401
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
401
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

649
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
649
Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

4.9K
The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
4.9K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

195
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
195

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Triple signal biosensing platform for ultrasensitive and wide-range detection of HLA gene targets.

Analytical methods : advancing methods and applications·2025
Same author

Loss of Nup160 dysregulates Cdc42 in the podocytes of podocyte-specific Nup160 knockout mice.

Human molecular genetics·2025
Same author

Time-restricted eating on weight loss: implications from the TREATY study.

Life medicine·2025
Same author

<i>Col4a2</i> Mutations Contribute to Infantile Epileptic Spasm Syndrome and Neuroinflammation.

International journal of medical sciences·2024
Same author

Effect of time-restricted eating regimen on weight loss is mediated by gut microbiome.

iScience·2024
Same author

Sex Hormone-Binding Globulin and Risk of Incident Dementia in Middle-Aged to Older Women: Results from the UK Biobank Cohort Study.

Neuroendocrinology·2023

Related Experiment Video

Updated: Jan 7, 2026

Mixed Reality Assisted Radical Endoscopic Thyroidectomy
08:06

Mixed Reality Assisted Radical Endoscopic Thyroidectomy

Published on: January 31, 2025

632

Levothyroxine dose prediction post-thyroidectomy for differentiated thyroid carcinoma.

Li Ma1, Yan Xie1, Sujie Ke1

  • 1Department of Endocrinology, Fujian Institute of Endocrinology, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.

Frontiers in Endocrinology
|January 2, 2026
PubMed
Summary

This study developed a new levothyroxine dosing model for differentiated thyroid carcinoma patients, improving accuracy in achieving thyroid-stimulating hormone suppression, especially for those with higher body mass index.

Keywords:
TSH suppression therapydifferentiated thyroid carcinomalevothyroxine dose predictionoverweight and obesitytotal thyroidectomy

More Related Videos

Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy
05:12

Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy

Published on: May 12, 2023

4.6K
Minimal Invasive Resection of Large Retrosternal Thyroid Goiter
04:09

Minimal Invasive Resection of Large Retrosternal Thyroid Goiter

Published on: September 20, 2024

768

Related Experiment Videos

Last Updated: Jan 7, 2026

Mixed Reality Assisted Radical Endoscopic Thyroidectomy
08:06

Mixed Reality Assisted Radical Endoscopic Thyroidectomy

Published on: January 31, 2025

632
Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy
05:12

Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy

Published on: May 12, 2023

4.6K
Minimal Invasive Resection of Large Retrosternal Thyroid Goiter
04:09

Minimal Invasive Resection of Large Retrosternal Thyroid Goiter

Published on: September 20, 2024

768

Area of Science:

  • Endocrinology
  • Oncology
  • Pharmacology

Background:

  • Levothyroxine (L-T4) overestimation is common in overweight/obese individuals.
  • Accurate L-T4 dosing is crucial for TSH suppression post-thyroidectomy in differentiated thyroid carcinoma (DTC).

Purpose of the Study:

  • To identify optimal body weight metrics for L-T4 dosing in DTC patients.
  • To develop an accurate L-T4 dosing model for TSH suppression based on BMI and weight metrics.

Main Methods:

  • Retrospective analysis of 385 DTC patients stratified by TSH targets and BMI.
  • Linear regression to correlate L-T4 dose with various weight metrics.
  • Model validation using a hold-out method and comparison with empirical dosing.

Main Results:

  • Higher BMI correlated with higher total L-T4 doses but lower weight-adjusted doses.
  • Adjusted body weight was optimal for BMI ≤ 23.9 kg/m², lean body weight for BMI ≥ 24.0 kg/m².
  • The new model improved accurate initial L-T4 dose prediction (68.0% vs. 30.2%).

Conclusions:

  • A BMI-stratified L-T4 dosing formula using optimized weight metrics enhances accuracy.
  • This approach expedites TSH suppression and may reduce adverse events in DTC patients.